GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (XPAR:ALSEN) » Definitions » Other Stockholders Equity

Sensorion (XPAR:ALSEN) Other Stockholders Equity : €0.18 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Sensorion Other Stockholders Equity?

Sensorion's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €0.18 Mil.

Sensorion's quarterly Other Stockholders Equity declined from Dec. 2023 (€0.04 Mil) to Jun. 2024 (€-36.57 Mil) but then increased from Jun. 2024 (€-36.57 Mil) to Dec. 2024 (€0.18 Mil).

Sensorion's annual Other Stockholders Equity increased from Dec. 2022 (€-13.58 Mil) to Dec. 2023 (€0.04 Mil) and increased from Dec. 2023 (€0.04 Mil) to Dec. 2024 (€0.18 Mil).

Sensorion Other Stockholders Equity Historical Data

The historical data trend for Sensorion's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensorion Other Stockholders Equity Chart

Sensorion Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.59 -13.58 0.04 0.18

Sensorion Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.58 -36.81 0.04 -36.57 0.18

Sensorion Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Sensorion Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sensorion's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensorion Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (XPAR:ALSEN) » Definitions » Other Stockholders Equity
Comparable Companies
XPAR:ADOC XPAR:TNG XPAR:ABNX XPAR:ALGAE XPAR:SIGHT XPAR:MAAT XPAR:ALGEN XPAR:POXEL XPAR:ALDVI XPAR:AELIS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
RFM:Germany
Address
375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Website
https://www.sensorion.com/en
Sensorion SA is a France-based clinical-stage biotech company dedicated to developing therapies to restore, treat, and prevent hearing loss. The company's product is in phase 2a clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies. The Company does business in a single operating segment: conducting research and development to discover drugs to treat inner ear disorders with a view to their future marketing. The company's pipeline programs are SENS-401 SSNHL, SENS-401 CIO, GJB2-GT, GJB2-GT, SENS-401 Cochlear, and others.

Sensorion Headlines

No Headlines